Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q4 2019 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$214.00K$214.00Kderived+107.8% vs Q4 2018 Net Income-$3.50M-$3.50MderivedN/M vs Q4 2018 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$3,537,000N/M Operating Cash Flowderived-$3,256,000N/M Free Cash Flowderived-$3,258,000N/M Margins · derivedOperating margin-1652.8%+1900.6 pt vs Q4 2018
Net margin-1636.4%+1899.5 pt vs Q4 2018
ended Dec 31, 2019 · filed Apr 9, 2020 · 100 d after period end